Oriental Aromatics Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/v1z9nxalqcyamzabzu348732.pdf

Key Takeaways


Fragrance: The Standout Performer

Shyamal Bodani: "We consciously traded off some top line growth in exchange for healthier margin and a stronger foundation. This prudence aligns with our long term view for the business, and we anticipated that as the cycle turns, Oriental Aromatics will be well positioned to capture the upside in camphene and terpene chemicals."

Camphor & Terpene Chemicals: A Year of Consolidation

Management: "That was in my opening speech where, it's a moat for us, because 60% we consume internally for our two brands. So even with the expanded capacity in the country, we currently stay relatively insulated from it."

Mahad: The Investment Phase Drag

Management: "We often speak about process efficiency and moving up the value chain. Evermoss is a prime example of that philosophy in action."

Specialty Aroma Ingredients: Volume Up, Price Under Pressure


Margins: Compression with a Recovery Path

Management: "it's our approach and our philosophy that we want to be cautiously optimistic and keep it in the 10 to 12 range and try to get it better and under commit and over deliver."

Strategic Levers & External Tailwinds

Parag Satoskar: "When it came to the fragrance division we were seeing certain aroma chemicals and essential oils which were at their lowest levels ever. So, it was a strategic decision to probably maintain a bit of higher inventories there."

Guidance & Commitments

CommitmentSpecificsTimeline
EBITDA margin10% to 12% rangeOngoing (no change from prior year)
Gross margin39% to 40% levelOngoing
Mahad top-line contributionFull contribution to reflectFY26 and beyond
Mahad turnover ratioConservative 1.4 to 1.5x on investmentNo specific quarter given
Volume growth (aroma chemicals & F&F)Double-digitTargeted
Volume growth (camphor)Single-digit or steadyTargeted
Future CAPEXOnly when very specific targeted opportunities arise; focus on stabilization and capacity utilization of existing plantsNear term

Key Metrics

MetricQ4 FY25
Operating revenue₹253 crore, +17% YoY and +13.7% QoQ
EBITDA₹19 crore, vs ₹22 crore in Q3 FY25 and ₹20.9 crore in Q4 FY24
EBITDA margin7.62%, vs 10.15% in Q3 FY25
Net profit after tax₹1.4 crore
Gross margin~38%, compressed from 40% in Q3 FY25; raw material price increases and one-time sales promotion expenses cited
FY25 operating revenue₹928 crore, +11% YoY
FY25 EBITDA₹93.4 crore, nearly doubling YoY
FY25 EBITDA margin10.06%, up from 5.62% in FY24
FY25 net profit after tax₹34.3 crore, up from ₹9.1 crore in FY24
FY25 PAT margin3.69%, +260 bps YoY
FY25 cash profit₹58 crore, vs ₹28.9 crore in FY24
FY25 return on capital employed9.33%, vs 3.90% in FY24
Mahad subsidiary loss₹5.9 crore in Q4, ₹11.74 crore in FY25; primary reason for 1.35% reduction in consolidated EBITDA
EBITDA margin guidance10% to 12%, management reaffirmed
Camphor and terpene sales volumesFlat YoY for FY25
Powder camphor internal consumption60% of total production, consumed by Saraswati and 3 Pine brands
Revenue mix by division~one-third each: camphor and terpene chemicals, specialty aroma ingredients, fragrance and flavor
Mahad Evermoss initial capacity250 metric tons
Export exposure46% of total revenue